Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Jun;61(6):1683–1690. doi: 10.1172/JCI109089

Methscopolamine Inhibition of Sleep-Related Growth Hormone Secretion

EVIDENCE FOR A CHOLINERGIC SECRETORY MECHANISM

Wallace B Mendelson 1,2,3,4, Natarajan Sitaram 1,2,3,4, Richard Jed Wyatt 1,2,3,4, J Christian Gillin 1,2,3,4, Laurence S Jacobs 1,2,3,4
PMCID: PMC372695  PMID: 659621

Abstract

We have examined the effects of cholinergic blockade with 0.5 mg methscopolamine bromide, intramuscularly, on sleep-related and insulin-induced growth hormone (GH) secretion. 17 normal young men were studied; 8 had sleep studies, and 12 (including 3 who also had sleep studies) had insulin tolerance tests (ITT) with 0.1 U/kg of regular insulin. After an adjustment night in the sleep laboratory, saline control night and methscopolamine night studies were done in random sequence; study procedures included electroencephalographic, electromyographic, and electrooculographic recordings, and blood sampling every 20 min for hormone radioimmunoassays. Prolactin levels were also measured during sleep. For methscopolamine night studies, the mean overall control GH level of 2.89±0.44 ng/ml and the mean peak control GH level of 11.09±3.11 ng/ml were dramatically reduced to 0.75±0.01 and 1.04±0.25 ng/ml, respectively (P<0.0001 and <0.001). Despite virtual absence of GH secretion during the night in every study subject, no measured sleep characteristic was affected by methscopolamine, including total slow-wave sleep (12.1±2.6% control vs. 10.3±2.5% drug, P>0.2). Sleep prolactin levels were not changed by methscopolamine. In contrast to the abolition of sleep-related GH secretion, administration of methscopolamine had only a marginal effect on the GH response to insulin hypoglycemia. None of nine time points differed significantly, as was also the case with peak levels, mean increments, and areas under the curves (P>0.2). Analysis of variance did, however, indicate that the lower GH concentrations achieved during ITT after methscopolamine (average 31.7% below control) were significantly different than control concentrations. We conclude that the burst of GH secretion which normally occurs after sleep onset is primed by a cholinergic mechanism which does not influence slow-wave sleep. Cholinergic mechanisms do not appear to play an important role in sleep-related prolactin secretion. The contrast between the complete suppression of sleep-related GH release and the relatively small inhibitory effect on ITT-induced GH secretion suggests that the neurotransmitter mechanisms, and presumably the pathways, which subserve sleep-related GH secretion in man may be different from those which mediate the GH response to pharmacologic stimuli such as insulin.

Full text

PDF
1683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlson H. E., Gillin J. C., Gorden P., Snyder F. Abscence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly. J Clin Endocrinol Metab. 1972 Jun;34(6):1102–1105. doi: 10.1210/jcem-34-6-1102. [DOI] [PubMed] [Google Scholar]
  2. Chihara K., Kato Y., Maeda K., Matsukura S., Imura H. Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep. J Clin Invest. 1976 Jun;57(6):1393–1402. doi: 10.1172/JCI108408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Domino E. F., Corssen G. Central and peripheral effects of muscarinic cholinergic blocking agents in man. Anesthesiology. 1967 May-Jun;28(3):568–574. [PubMed] [Google Scholar]
  4. Donoso A. O., Bacha J. C. Role of the blood-brain barrier in the anticholinergic differential effects on LH and prolactin release in proestrous rats. J Neural Transm. 1975;37(2):155–164. doi: 10.1007/BF01663630. [DOI] [PubMed] [Google Scholar]
  5. Granacher R. P., Baldessarini R. J. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry. 1975 Mar;32(3):375–380. doi: 10.1001/archpsyc.1975.01760210109008. [DOI] [PubMed] [Google Scholar]
  6. Grandison L., Gelato M., Meites J. Inhibition of prolactin secretion by cholinergic drug. Proc Soc Exp Biol Med. 1974 Apr;145(4):1236–1239. doi: 10.3181/00379727-145-37988. [DOI] [PubMed] [Google Scholar]
  7. Grandison L., Meites J. Evidence for adrenergic mediation of cholinergic inhibition of prolactin release. Endocrinology. 1976 Sep;99(3):775–779. doi: 10.1210/endo-99-3-775. [DOI] [PubMed] [Google Scholar]
  8. Herington A. C., Jacobs L. S., Daughaday W. H. Radioreceptor and radioimmunoassay quantitation of human growth hormone in acromegalic serum: overestimation by immunoassay and systematic differences between antisera. J Clin Endocrinol Metab. 1974 Aug;39(2):257–262. doi: 10.1210/jcem-39-2-257. [DOI] [PubMed] [Google Scholar]
  9. Honda Y., Takahashi K., Takahashi S., Azumi K., Irie M., Sakuma M., Tsushima T., Shizume K. Growth hormone secretion during nocturnal sleep in normal subjects. J Clin Endocrinol Metab. 1969 Jan;29(1):20–29. doi: 10.1210/jcem-29-1-20. [DOI] [PubMed] [Google Scholar]
  10. Libertun C., McCann S. M. Further evidence for cholinergic control of gonadotropin and prolactin secretion. Proc Soc Exp Biol Med. 1974 Nov;147(2):498–504. doi: 10.3181/00379727-147-38374. [DOI] [PubMed] [Google Scholar]
  11. Lipman R. L., Taylor A. L., Schenk A., Mintz D. H. Inhibition of sleep related growth hormone release by elevated free fatty acids. J Clin Endocrinol Metab. 1972 Oct;35(4):592–594. doi: 10.1210/jcem-35-4-592. [DOI] [PubMed] [Google Scholar]
  12. Lucke C., Glick S. M. Effect of medroxyprogesterone acetate on the sleep induced peak of growth hormone secretion. J Clin Endocrinol Metab. 1971 Nov;33(5):851–853. doi: 10.1210/jcem-33-5-851. [DOI] [PubMed] [Google Scholar]
  13. Lucke C., Glick S. M. Experimental modification of the sleep-induced peak of growth hormone secretion. J Clin Endocrinol Metab. 1971 Jun;32(6):729–736. doi: 10.1210/jcem-32-6-729. [DOI] [PubMed] [Google Scholar]
  14. Malick J. B., Barnett A. Central versus peripheral anticholinergic activity as assessed by two in vivo procedures in mice. J Pharm Sci. 1975 Jun;64(6):1066–1068. doi: 10.1002/jps.2600640650. [DOI] [PubMed] [Google Scholar]
  15. McLean B. K., Nikitovitch-Winer M. B. Cholinergic control of the nocturnal prolactin surge in the pseudopregnant rat. Endocrinology. 1975 Oct;97(4):763–770. doi: 10.1210/endo-97-4-763. [DOI] [PubMed] [Google Scholar]
  16. Mendelson W. B., Jacobs L. S., Reichman J. D., Othmer E., Cryer P. E., Trivedi B., Daughaday W. H. Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion. J Clin Invest. 1975 Sep;56(3):690–697. doi: 10.1172/JCI108139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Othmer E., Levine W. R., Malarkey W. B., Corvalan J. C., Hayden-Otto M. P., Fishman P. M., Daughaday W. H. Body build and sleep-related growth hormone secretion. Horm Res. 1974;5(3):156–166. doi: 10.1159/000178626. [DOI] [PubMed] [Google Scholar]
  18. Parker D. C., Rossman L. G. Human growth hormone release in sleep: nonsuppression by acute hyperglycemia. J Clin Endocrinol Metab. 1971 Jan;32(1):65–69. doi: 10.1210/jcem-32-1-65. [DOI] [PubMed] [Google Scholar]
  19. Parker D. C., Rossman L. G., Siler T. M., Rivier J., Yen S. S., Guillemin R. Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin. J Clin Endocrinol Metab. 1974 Mar;38(3):496–499. doi: 10.1210/jcem-38-3-496. [DOI] [PubMed] [Google Scholar]
  20. Parker D. C., Rossman L. G., Vander Laan E. F. Sleep-related, nychthermeral and briefly episodic variation in human plasma prolactin concentrations. J Clin Endocrinol Metab. 1973 Jun;36(6):1119–1124. doi: 10.1210/jcem-36-6-1119. [DOI] [PubMed] [Google Scholar]
  21. Parker D. C., Rossman L. G., Vanderlaan E. F. Relation of sleep-entrained human prolactin release to REM-nonREM cycles. J Clin Endocrinol Metab. 1974 Apr;38(4):646–651. doi: 10.1210/jcem-38-4-646. [DOI] [PubMed] [Google Scholar]
  22. Parker D. C., Sassin J. F., Mace J. W., Gotlin R. W., Rossman L. G. Human growth hormone release during sleep: electroencephalographic correlation. J Clin Endocrinol Metab. 1969 Jun;29(6):871–874. doi: 10.1210/jcem-29-6-871. [DOI] [PubMed] [Google Scholar]
  23. Perlow M., Sassin J., Boyar R., Hellman L., Weitzman E. D. Reduction of growth hormone secretion following clomiphene administration. Metabolism. 1973 Oct;22(10):1269–1275. doi: 10.1016/0026-0495(73)90272-2. [DOI] [PubMed] [Google Scholar]
  24. Powell G. F., Hopwood N. J., Barratt E. S. Growth hormone studies before and during catch-up growth in a child with emotional deprivation and short stature. J Clin Endocrinol Metab. 1973 Nov;37(5):674–679. doi: 10.1210/jcem-37-5-674. [DOI] [PubMed] [Google Scholar]
  25. Quabbe H. J., Helge H., Kubicki S. Nocturnal growth hormone secretion: correlation with sleeping EEG in adults and pattern in children and adolescents with non-pituitary dwarfism, overgrowth and with obesity. Acta Endocrinol (Copenh) 1971;67(4):767–783. doi: 10.1530/acta.0.0670767. [DOI] [PubMed] [Google Scholar]
  26. Rubin R. T., Gouin P. R., Arenander A. T., Poland R. E. Human growth hormone release during sleep following prolonged flurazepam administration. Res Commun Chem Pathol Pharmacol. 1973 Jul;6(1):331–334. [PubMed] [Google Scholar]
  27. SCHALCH D. S., PARKER M. L. A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA. Nature. 1964 Sep 12;203:1141–1142. doi: 10.1038/2031141a0. [DOI] [PubMed] [Google Scholar]
  28. Sagales T., Erill S., Domino E. F. Differential effects of scopolamine and chlorpromazine on REM and NREM sleep in normal male subjects. Clin Pharmacol Ther. 1969 Jul-Aug;10(4):522–529. doi: 10.1002/cpt1969104522. [DOI] [PubMed] [Google Scholar]
  29. Salvadorini F., Galeone F., Nicotera M., Ombrato M., Saba P. Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment. Curr Ther Res Clin Exp. 1975 Sep;18(3):513–520. [PubMed] [Google Scholar]
  30. Sassin J. F., Frantz A. G., Kapen S., Weitzman E. D. The nocturnal rise of human prolactin is dependent on sleep. J Clin Endocrinol Metab. 1973 Sep;37(3):436–440. doi: 10.1210/jcem-37-3-436. [DOI] [PubMed] [Google Scholar]
  31. Sassin J. F., Frantz A. G., Weitzman E. D., Kapen S. Human prolactin: 24-hour pattern with increased release during sleep. Science. 1972 Sep 29;177(4055):1205–1207. doi: 10.1126/science.177.4055.1205. [DOI] [PubMed] [Google Scholar]
  32. Schnure J. J., Raskin P., Lipman R. L. Growth hormone secretion during sleep: impairment in glucose tolerance and nonsuppressibility by hyperglycemia. J Clin Endocrinol Metab. 1971 Aug;33(2):234–241. doi: 10.1210/jcem-33-2-234. [DOI] [PubMed] [Google Scholar]
  33. Sinha Y. N., Selby F. W., Lewis U. J., VanderLaan W. P. A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1973 Mar;36(3):509–516. doi: 10.1210/jcem-36-3-509. [DOI] [PubMed] [Google Scholar]
  34. Takahashi Y., Kipnis D. M., Daughaday W. H. Growth hormone secretion during sleep. J Clin Invest. 1968 Sep;47(9):2079–2090. doi: 10.1172/JCI105893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. VanderLaan W. P., Parker D. C., Rossman L. G., VanderLaan E. F. Implications of growth hormone release in sleep. Metabolism. 1970 Oct;19(10):891–897. doi: 10.1016/0026-0495(70)90086-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES